Be Vigilant When Starting Meds in Patients Taking Hep C Antivirals

July 2019

You'll face MANY potential drug interactions with hepatitis C antivirals (Epclusa, Mavyret, etc)...even if you didn't start these meds.

Interactions can lead to toxicity...or treatment failure. And this can be an expensive mistake...since antivirals cost up to $95,000/course.

Plus hep C meds may fly under the radar if you didn't prescribe them. Update the EHR with ALL meds...Rxs, OTCs, supplements, etc.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Asthma Consider a PRN Combo Inhaler for Some Adults With Mild Asthma
Cardiology Optimize Meds for Peripheral Artery Disease
Diabetes Simplify Type 2 Diabetes Regimens in Older Adults
HIV & AIDS Watch for Dovato, a New Two-Med Combo for HIV
Hemorrhoids Help Patients Navigate Treatments for Hemorrhoids
Hepatitis C Be Vigilant When Starting Meds in Patients Taking Hep C Antivirals
Public Health Recognize Human Trafficking Victims Hidden in Plain Sight
Devices Put Sensors for Inhalers in Perspective
Statins Evaluate CV Risks When Considering Statins for Patients Under Age 40
Drug Costs Be Prepared for Questions About Medication Prices in TV Ads
MRSA Don't Switch From Vancomycin for MRSA Bacteremia Just for an MIC of 2 mg/L
Allergic Reactions Sort Through Options When Treating Patients Reporting a Penicillin Allergy